Insights from Pasteur Institute's Sequencing of Andes Virus from MV Hondius Passenger
France's Pasteur Institute has successfully sequenced the Andes virus found in a French passenger from the MV Hondius cruise ship. The institute confirmed that the virus closely matched known viruses in South America, showing no signs of new characteristics that would increase its transmissibility or danger. Health Minister Stéphanie Rist stated that the analyzed virus corresponds to existing viruses in South America, with no indication of a more concerning form emerging.
Genomic analysis by Pasteur revealed that the virus in the French passenger aligned with viruses detected in other cases on the ship and resembled known Andes virus strains in circulation in South America. This sequencing work provides valuable insights into the virus and enables close health monitoring. The data will be shared with the global scientific community to enhance understanding of the virus.
The viruses identified in patients from the MV Hondius were genetically identical to each other and shared about 97% similarity with certain Andes viruses found in South America, including those in rodents. Jean-Claude Manuguerra, head of Pasteur's Environment and Infectious Risk unit, noted that the minor variations observed likely represent natural viral diversity and do not impact the virus's characteristics among travelers.
Following a positive test result for the French passenger who had traveled on the MV Hondius, she received treatment in Paris and was reported to be in serious condition. Pasteur Institute continues its virological investigations in collaboration with French health authorities and international partners to further study the Andes virus and its implications.
In conclusion, France's Pasteur Institute's sequencing of the Andes virus from the MV Hondius cruise ship passenger has provided valuable insights into the virus's genetic makeup and its relation to known strains in South America. The findings suggest no significant changes in the virus's transmissibility or severity, reassuring health authorities and the public about the situation. Ongoing collaboration and research efforts aim to enhance understanding and monitoring of the virus for effective public health measures.